4 assets in Nutritional Deficiency Disease

Therapeutic assets addressing Nutritional Deficiency Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Nanocrystalline Megestrol Acetate Suspension Nutritional Deficiency Disease	Nanfang Hospital, Southern Medical University	P2	CCC (53)
pf-08653944 Nutritional Deficiency Disease	Pfizer	P2	CCC (53)
pf-08653945 Nutritional Deficiency Disease	Pfizer	P2	CCC (53)